Recurrence of acute myelogenous leukemia with granulocytic sarcoma-associated tarsal tunnel syndrome in an elderly patient

2018 ◽  
Vol 23 (3) ◽  
pp. 596-599
Author(s):  
Osamu Obayashi ◽  
Hiroyuki Obata ◽  
Kiyohito Naito ◽  
Akio Kanda ◽  
Akira Itoi ◽  
...  
Hematology ◽  
2010 ◽  
Vol 2010 (1) ◽  
pp. 62-69 ◽  
Author(s):  
Selina M. Luger

Abstract Decisions regarding the optimal treatment of acute myelogenous leukemia in the elderly patient requires the consideration of multiple factors. Population-based studies have demonstrated that, for all age groups, aggressive therapy results in improved survival and quality of life when compared with palliative care. The optimal induction and postremission regimen for older patients has yet to be determined. Furthermore, not all patients are candidates for such therapy. Consideration of patient and disease-related factors can help to determine the appropriateness of intensive therapy in a given patient. For those patients for whom aggressive induction therapy does not seem to be in their best interest, novel agents are being investigated that will hopefully address the issues of induction death and early relapse associated with these patient populations.


1991 ◽  
Vol 38 (3) ◽  
pp. 223-225 ◽  
Author(s):  
Kou Yamamoto ◽  
Hideki Akiyama ◽  
Tamotsu Maruyama ◽  
Hisashi Sakamaki ◽  
Yasusuke Onozawa ◽  
...  

The Breast ◽  
2004 ◽  
Vol 13 (3) ◽  
pp. 242-246 ◽  
Author(s):  
S Dutta Roy ◽  
J.S Stafford ◽  
J Scally ◽  
S.N Selvachandran

Sign in / Sign up

Export Citation Format

Share Document